Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 1
2005 2
2006 1
2007 1
2008 1
2009 1
2010 3
2011 4
2012 2
2013 2
2014 1
2015 1
2016 4
2017 3
2018 10
2019 13
2020 19
2021 18
2022 19
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

101 results

Results by year

Filters applied: . Clear all
Page 1
Pharmacotherapy of Anxiety Disorders: Current and Emerging Treatment Options.
Garakani A, Murrough JW, Freire RC, Thom RP, Larkin K, Buono FD, Iosifescu DV. Garakani A, et al. Front Psychiatry. 2020 Dec 23;11:595584. doi: 10.3389/fpsyt.2020.595584. eCollection 2020. Front Psychiatry. 2020. PMID: 33424664 Free PMC article. Review.
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of disability. ...Posttraumatic stress disorder and obsessive-compulsive disorder are excluded from this review. ...
Anxiety disorders are the most prevalent psychiatric disorders and a leading cause of disability. ...Posttraumatic stress d …
Cannabidiol as a Potential Treatment for Anxiety and Mood Disorders: Molecular Targets and Epigenetic Insights from Preclinical Research.
Melas PA, Scherma M, Fratta W, Cifani C, Fadda P. Melas PA, et al. Int J Mol Sci. 2021 Feb 13;22(4):1863. doi: 10.3390/ijms22041863. Int J Mol Sci. 2021. PMID: 33668469 Free PMC article. Review.
Since CBD interacts with a wide variety of molecular targets in the brain, its therapeutic potential has been investigated in a number of neuropsychiatric diseases, including anxiety and mood disorders. Specifically, CBD has received growing attention due to its anx …
Since CBD interacts with a wide variety of molecular targets in the brain, its therapeutic potential has been investigated in a number of ne …
Psychobehavioural and Cognitive Adverse Events of Anti-Seizure Medications for the Treatment of Developmental and Epileptic Encephalopathies.
Strzelczyk A, Schubert-Bast S. Strzelczyk A, et al. CNS Drugs. 2022 Oct;36(10):1079-1111. doi: 10.1007/s40263-022-00955-9. Epub 2022 Oct 4. CNS Drugs. 2022. PMID: 36194365 Free PMC article. Review.
The latter include intellectual disability, developmental delay, behavioural problems including attention-deficit hyperactivity disorder and autism spectrum disorder, psychiatric problems including anxiety and depression, speech impairment and sleep problems. ...We …
The latter include intellectual disability, developmental delay, behavioural problems including attention-deficit hyperactivity disorder …
A scoping review of the use of cannabidiol in psychiatric disorders.
Kirkland AE, Fadus MC, Gruber SA, Gray KM, Wilens TE, Squeglia LM. Kirkland AE, et al. Psychiatry Res. 2022 Feb;308:114347. doi: 10.1016/j.psychres.2021.114347. Epub 2021 Dec 20. Psychiatry Res. 2022. PMID: 34952255 Free PMC article. Review.
Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and clinicians are challenged with understanding the implications of CBD for treating mental health disorders. ...There were no published studies that met inclusion criteria for alcohol o …
Cannabidiol (CBD) has become a fast-growing avenue for research in psychiatry, and clinicians are challenged with understanding the i …
The Effects of Cannabinoids on Sleep.
Kolla BP, Hayes L, Cox C, Eatwell L, Deyo-Svendsen M, Mansukhani MP. Kolla BP, et al. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221081277. doi: 10.1177/21501319221081277. J Prim Care Community Health. 2022. PMID: 35459406 Free PMC article. Review.
Our comprehensive review of the effects of cannabis products on normal sleep and sleep disorders, relevant to primary care providers and other clinicians evaluating and treating patients who use these types of products, shows that cannabis products have minimal to no effec …
Our comprehensive review of the effects of cannabis products on normal sleep and sleep disorders, relevant to primary care providers …
Association of Cannabis Use in Adolescence and Risk of Depression, Anxiety, and Suicidality in Young Adulthood: A Systematic Review and Meta-analysis.
Gobbi G, Atkin T, Zytynski T, Wang S, Askari S, Boruff J, Ware M, Marmorstein N, Cipriani A, Dendukuri N, Mayo N. Gobbi G, et al. JAMA Psychiatry. 2019 Apr 1;76(4):426-434. doi: 10.1001/jamapsychiatry.2018.4500. JAMA Psychiatry. 2019. PMID: 30758486 Free PMC article.
While the impact of adolescent cannabis use on the development of psychosis has been investigated in depth, little is known about the impact of cannabis use on mood and suicidality in young adulthood. OBJECTIVE: To provide a summary estimate of the extent to which cannabis …
While the impact of adolescent cannabis use on the development of psychosis has been investigated in depth, little is known about the impact …
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
Sarris J, Sinclair J, Karamacoska D, Davidson M, Firth J. Sarris J, et al. BMC Psychiatry. 2020 Jan 16;20(1):24. doi: 10.1186/s12888-019-2409-8. BMC Psychiatry. 2020. PMID: 31948424 Free PMC article.
METHODS: The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric disorders was conducted. Current evidence regarding whole plant formulations and plant-derived cannabinoid isolates in mood, anxiety, …
METHODS: The first clinically-focused systematic review on the emerging medical application of cannabis across all major psychiatric diso …
Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
Bonaccorso S, Ricciardi A, Zangani C, Chiappini S, Schifano F. Bonaccorso S, et al. Neurotoxicology. 2019 Sep;74:282-298. doi: 10.1016/j.neuro.2019.08.002. Epub 2019 Aug 11. Neurotoxicology. 2019. PMID: 31412258 Review.
Cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. ...There is currently limited evidence regarding the safety and efficacy of CBD for the treatment of psychiatric disorders. However, availab …
Cannabidiol (CBD) and delta9-tetrahydrocannabinol (THC) are the most represented phytocannabinoids in Cannabis sativa plants. ...Ther …
Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.
Stanciu CN, Brunette MF, Teja N, Budney AJ. Stanciu CN, et al. Psychiatr Serv. 2021 Apr 1;72(4):429-436. doi: 10.1176/appi.ps.202000189. Epub 2021 Feb 3. Psychiatr Serv. 2021. PMID: 33530732 Free PMC article.
OBJECTIVE: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), differentially and dose-dependently affect mood and anxiety. In this systematic review, the authors summarize the design and results o …
OBJECTIVE: Two primary compounds of the cannabis plant (Cannabis sativa), delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), d …
The "Entourage Effect": Terpenes Coupled with Cannabinoids for the Treatment of Mood Disorders and Anxiety Disorders.
Ferber SG, Namdar D, Hen-Shoval D, Eger G, Koltai H, Shoval G, Shbiro L, Weller A. Ferber SG, et al. Curr Neuropharmacol. 2020;18(2):87-96. doi: 10.2174/1570159X17666190903103923. Curr Neuropharmacol. 2020. PMID: 31481004 Free PMC article. Review.
Mood disorders are the most prevalent mental conditions encountered in psychiatric practice. Numerous patients suffering from mood disorders present with treatment-resistant forms of depression, co-morbid anxiety, other psychiatric disorders and …
Mood disorders are the most prevalent mental conditions encountered in psychiatric practice. Numerous patients suffering from …
101 results